These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15100646)

  • 1. Flutamide as a preoperative treatment in juvenile angiofibroma (JA) with intracranial invasion: report of 7 cases.
    Labra A; Chavolla-Magaña R; Lopez-Ugalde A; Alanis-Calderon J; Huerta-Delgado A
    Otolaryngol Head Neck Surg; 2004 Apr; 130(4):466-9. PubMed ID: 15100646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy with flutamide for presurgical volume reduction in juvenile nasopharyngeal angiofibroma.
    Thakar A; Gupta G; Bhalla AS; Jain V; Sharma SC; Sharma R; Bahadur S; Deka RC
    Head Neck; 2011 Dec; 33(12):1747-53. PubMed ID: 22076979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flutamide-induced regression of angiofibroma.
    Gates GA; Rice DH; Koopmann CF; Schuller DE
    Laryngoscope; 1992 Jun; 102(6):641-4. PubMed ID: 1318484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal Fluid Leak in Juvenile Nasopharyngeal Angiofibroma-Rare Sequelae of Flutamide-Induced Tumor Shrinkage.
    Panda S; Phalak M; Thakar A; Dharanipathy S
    World Neurosurg; 2018 Dec; 120():78-81. PubMed ID: 30099189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of flutamide for the neoadjuvant treatment of juvenile nasopharyngeal angiofibroma: a review of the literature comparing results by pubertal status and tumor stage.
    Sitenga G; Granger P; Hepola K; Aird J; Silberstein PT
    Int J Dermatol; 2022 Nov; 61(11):1346-1352. PubMed ID: 34748211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study.
    Sato N; Akakura K; Isaka S; Nakatsu H; Tanaka M; Ito H; Masai M;
    Urology; 2004 Aug; 64(2):341-5. PubMed ID: 15302491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile nasopharyngeal angiofibroma: analysis of 42 cases and important aspects of endoscopic approach.
    Midilli R; Karci B; Akyildiz S
    Int J Pediatr Otorhinolaryngol; 2009 Mar; 73(3):401-8. PubMed ID: 19124161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
    Miyake H; Hara I; Eto H
    BJU Int; 2005 Oct; 96(6):791-5. PubMed ID: 16153202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the treatment of juvenile angiofibroma.
    Enepekides DJ
    Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):495-9. PubMed ID: 15548906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of invasive juvenile nasopharyngeal angiofibromas: the role of a multimodality approach.
    Roche PH; Paris J; Régis J; Moulin G; Zanaret M; Thomassin JM; Pellet W
    Neurosurgery; 2007 Oct; 61(4):768-77; discussion 777. PubMed ID: 17986938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exclusively endoscopic surgery for juvenile nasopharyngeal angiofibroma.
    Andrade NA; Pinto JA; Nóbrega Mde O; Aguiar JE; Aguiar TF; Vinhaes ES
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):492-6. PubMed ID: 17765782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nasopharyngeal angiofibroma with intracranial extension: situating the chemotherapy-radiotherapy association].
    Belcadhi M; Mani R; Harzallah M; Bouaouina N; Bouzouita K
    Cancer Radiother; 2008 Sep; 12(5):385-8. PubMed ID: 18339570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of juvenile angiofibroma--an alternative?].
    Schick B; Kahle G; Hässler R; Draf W
    HNO; 1996 Mar; 44(3):148-52. PubMed ID: 8641902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transnasal endoscopic resection of juvenile nasopharyngeal angiofibroma without preoperative embolization.
    Borghei P; Baradaranfar MH; Borghei SH; Sokhandon F
    Ear Nose Throat J; 2006 Nov; 85(11):740-3, 746. PubMed ID: 17168151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex hormones in juvenile nasopharyngeal angiofibroma tissue.
    Kumagami H
    Auris Nasus Larynx; 1993; 20(2):131-5. PubMed ID: 8216048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy.
    Davis NB; Ryan CW; Stadler WM; Vogelzang NJ
    BJU Int; 2005 Oct; 96(6):787-90. PubMed ID: 16153201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent and residual juvenile angiofibromas.
    Tyagi I; Syal R; Goyal A
    J Laryngol Otol; 2007 May; 121(5):460-7. PubMed ID: 17210091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging and surgical approaches in large juvenile angiofibroma--study of 95 cases.
    Tyagi I; Syal R; Goyal A
    Int J Pediatr Otorhinolaryngol; 2006 Sep; 70(9):1619-27. PubMed ID: 16777240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical approaches for nasopharyngeal angiofibroma: comparative analysis and current trends.
    Tosun F; Ozer C; Gerek M; Yetiser S
    J Craniofac Surg; 2006 Jan; 17(1):15-20. PubMed ID: 16432402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of flutamide on survival in patients with pancreatic cancer. Results are impressive.
    Wigmore SJ; Fearon KC; Garden OJ
    BMJ; 1999 Jan; 318(7179):327; author reply 328. PubMed ID: 10075463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.